GeoVax Labs, Inc. License Agreements
5 Contracts & Agreements
- Amendment to Exclusive License Agreement, dated April 11, 2023, between GeoVax, Inc. and City of Hope (Filed With SEC on May 4, 2023)
- Exclusive License Agreement, dated November 9, 2021, by and between GeoVax, Inc. and City of Hope (Filed With SEC on November 10, 2021)
- Assignment and License Agreement, dated September 28, 2021, by and between GeoVax, Inc. and PNP Therapeutics, Inc (Filed With SEC on September 29, 2021)
- Patent and Biological Materials License Agreement for Internal Research Use with the National Institute of Allergy and Infectious Diseases, dated November 25, 2020 (Filed With SEC on November 30, 2020)
- Patent and Biological Materials License Agreement with the National Institute of Allergy and Infectious Diseases, dated October 22, 2020 (Filed With SEC on October 26, 2020)
